Clinical Trial Update: Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase II study assessing neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Esophageal Cancer, Chemoradiation | Phase 2 | Status: UNKNOWN